Archives: “Archives”

Showing 31 - 40 of 56 posts

Jason Christie, MD, MSCE

https://www.coltonconsortium.org/directory/jason-christie-md-msce/

Paul F. Harron, Jr. Family Chair, Department of Medicine, Perelman School of Medicine, University of Pennsylvania Dr. Jason Christie is the Paul F. Harron, Jr. Family Chair, Chief of the […]

Jill P. Buyon, MD

https://www.coltonconsortium.org/directory/jill-p-buyon-md/

Sir Deryck and Lady Va Maughan Professor of Rheumatology, Department of Medicine, NYU Grossman School of Medicine / NYU Langone Health Director, Division of Rheumatology, NYU Grossman School of Medicine […]

Benjamin Abramoff, MD, MS

https://www.coltonconsortium.org/directory/benjamin-abramoff-md-ms/

Associate Professor, Department of Physical Medicine and Rehabilitation, Perelman School of Medicine, University of Pennsylvania Dr. Benjamin Abramoff is an Assistant Professor of Physical Medicine and Rehabilitation at the Perelman […]

Amit Bar-Or, MD, FRCP, FAAN, FANA

https://www.coltonconsortium.org/directory/amit-bar-or-md-frcp-faan-fana/

Melissa and Paul Anderson President’s Distinguished Professor, Department of Neurology, Perelman School of Medicine, University of Pennsylvania Dr. Amit Bar-Or is the inaugural Melissa and Paul Anderson President’s Distinguished Professor […]

Center of Excellence for Cell Therapy in Autoimmunity (CECTA)

https://www.coltonconsortium.org/projects/center-of-excellence-for-cell-therapy-in-autoimmunity-cecta/

Advancing engineered CAR and CAAR T cell therapies across multiple autoimmune diseases through clinical trials, preclinical development, and industry partnerships.

High-Throughput Center for AutoImmune Therapeutic Discovery (HIT-AI)

https://www.coltonconsortium.org/projects/high-throughput-center-for-autoimmune-therapeutic-discovery-hit-ai/

Systematically identifying and validating repurposed FDA-approved drugs for over 160 autoimmune diseases using AI, knowledge graphs, and high-throughput experimental screening.

Colton Center for RNA Exploration in Autoimmune Therapeutics (CREATE)

https://www.coltonconsortium.org/projects/colton-center-for-rna-exploration-in-autoimmune-therapeutics-create/

Developing next-generation mRNA-LNP therapeutics that selectively modulate or deplete pathogenic immune cells to treat type 1 diabetes, lupus, multiple sclerosis, and other severe autoimmune conditions.